Table 2

Operator and site factors versus the occurrence of a hemorrhagic stroke (n=13)

SAH or ICH
FactorNo of sites oroperatorsNo of patientsSAH (n (%))ICH (n (%))n (%)p ValueDifference (95% CI)†
SAMMPRIS site enrollment
 High (≥12)121111 (0.9)2 (1.8)3 (2.7)0.043−7.1% (−14.9% to 0.6%)
 Low (<12)361025 (4.9)5 (4.9)10 (9.8)
High enrolling registry site
 No381325 (3.8)5 (3.8)10 (7.6)0.383.9% (−4.0% to 10.5%)
 Yes10811 (1.2)2 (2.5)3 (3.7)
Primary specialty of interventionist
 Radiology391154 (3.5)3 (2.6)7 (6.1)0.0711: 3.3% (−6.6% to 11.7%)
 Neurosurgery18720 (0)2 (2.8)2 (2.8)2: −9.3% (−34.3% to 4.8%)
 Neurology6262 (7.7)2 (7.7)4 (15.4)3: 12.6% (−37.1% to 1.9%)
Credentialing: No of study devices
 <1030712 (2.8)2 (2.8)4 (5.6)0.99−0.7% (−7.3% to 8.1%)
 ≥10331424 (2.8)5 (3.5)9 (6.3)
Credentialing: No of aneurysm stents
 <6291163 (2.6)4 (3.4)7 (6.0)0.99−0.2% (−7.7% to 6.8%)
 ≥634973 (3.1)3 (3.1)6 (6.2)
No of years in practice
 <8281045 (4.8)3 (2.9)8 (7.7)0.403.1% (−3.8% to 10.8%)
 ≥8351091 (0.9)4 (3.7)5 (4.6)
No of SAMMPRIS PTAS cases
 <331432 (4.7)2 (4.7)4 (9.3)0.404.0% (−3.8% to 17.2%)
 ≥3321704 (2.4)5 (2.9)9 (5.3)
  • *p Value for Fisher's exact test comparing percentages among groups.

  • †Difference between percentages, calculated as first group − second group, except for primary specialty (1: radiology − neurosurgery, 2: radiology − neurology, 3: neurosurgery − neurology).

  • ‡Total in both groups exceeds 63 interventionists because individual interventionists had patients in both groups.

  • ICH, intraparenchymal hemorrhage; PTAS, percutaneous transluminal angioplasty and stenting; SAH, subarachnoid hemorrhage.